PharmaCyte Biotech Inc (PMCB)

[Edward]

BEST PART " This product will be used in the company’s planned clinical trial in locally advanced, inoperable pancreatic cancer upon the FDA lifting the clinical hold on PharmaCyte’s Investigational New Drug Application (IND)".

Totally meaningless.

No kidding upon lifting the hold, but the hold will never be lifted because PMCB will never supply them with acceptable test results as requested. None have at this point.

Should be obvious by now!!!

The Stability Study wasn't part of the hold. It was ongoing already, before the filing whereas only 3 months were required to file for the IND.

The statement means nothing! This is why PMCB still trades, a lot of naive investors in penny stocks.

and the information and data will form part of the package of information together with the data from additional studies requested by the FDA.

That doesn't mean it was part of the data requested by the FDA FOR THE HOLD. What it is data that has to be supplied over time for the 1st filing of the IND when only 3 months were needed, not the HOLD requested data they need to supply.

It is worded that way for the reason someone will misunderstand it and think it was part of the hold requested data.

How this isn't obvious by now? PMCB releases PR's every few months, but never satisfies anything the FDA needs for the HOLD!